1 September 2017

Osteoarthritis is the most prevalent and debilitating joint disease worldwide but no cure has been developed yet. Recent findings show that low grade inflammation within the OA joint may contribute to the pathophysiology and clinical symptoms.

Arjen Blom and Martijn van den Bosch, theme Inflammatory diseases will focus on the involvement of the Wnt-signaling induced protein WISP1 in cartilage destruction in osteoarthritis (OA). The sequence of events that leads to cartilage destruction  via WISP1 will be studied both in experimental OA and in a human trial.

Peter van Lent, theme Inflammatory diseases will focus on the therapeutic efficacy of PCSK9 inhibitors in dampening cholesterol driven synovial inflammation and joint destruction in OA. The group of Peter van Lent has significantly contributed in understanding the role of inflammation and joint destruction in osteoarthritis.
  

Arjen Blom                                Martijn van den Bosch             Peter van Lent

Related news items


Joyce Aarts and colleagues published in Scientific Reports about the role of TGF-β1 in (experimental) arthritis

30 March 2022

Joyce Aarts, theme Inflammatory diseases, and her colleagues published in Scientific Reports, that local inhibition of TGF-β1 signaling improves Th17/Treg balance but not joint pathology during experimental arthritis.

read more

Large NWA ORC grant awarded for national skin research: Next Generation ImmunoDermatology

23 March 2022

Research for better treatment methods for chronic skin diseases.

read more

OARSI Basic Science Award for Peter van der Kraan

22 May 2020

Purpose of this Basic Science Award of the Osteoarthritis Research Society International (OARSI) is to stimulate fundamental research in the field of osteoarthritis. Congratulations Peter.

read more

PPP allowance by Health~Holland for Fons van de Loo

16 December 2019

Fons van de Loo, theme Inflammatory diseases, has been granted a 3 year PPP Allowance made available by Health~Holland for the project ‘REFIT’. The goal of this project is to restore the barrier function, immunity and microbiome of the intestinal tract using extracellular vesicles from milk.

read more

Four Veni grants for junior RIMLS researchers

22 July 2019

Four junior researchers, affiliated to the RIMLS, have each received a Veni grant of 250,000 Euro from NWO. Our researchers received this prestigious grant for their remarkable and original talent and their ability to carry out innovative research.

read more

€600,000 EULAR grant for Peter van der Kraan

2 October 2017

European League against Rheumatism (EULAR).

read more